2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-

2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- Basic information
Pharmacological activity
Product Name:2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-
Synonyms:CL-387785 (EKI-785);N-(4-(3-bromophenylamino)quinazolin-6-yl)but-2-ynamide;N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-2-ButynaMide CL-387785;2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-;CL-387785, >=98%;785;EKI-785; WAY-EKI 785; CL387785; CL 387785; EKI785; WAY-EKI785; EKI 785;CL-387;785;CS-1630
CAS:194423-06-8
MF:C18H13BrN4O
MW:381.23
EINECS:
Product Categories:Inhibitors
Mol File:194423-06-8.mol
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- Structure
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- Chemical Properties
Melting point 276 °C
density 1.577±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility insoluble in EtOH; insoluble in H2O; ≥16.85 mg/mL in DMSO
form Off-white to yellow solid.
pka9.84±0.43(Predicted)
color White to Orange to Green
Safety Information
HS Code 2933.59.5300
MSDS Information
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- Usage And Synthesis
Pharmacological activityOveractivity of epidermal growth factor receptor (EGFR) tyrosine kinase activity has been associated with a number of cancers.CL 387,785 profoundly blocks the growth of EGFR-overexpressing tumors in nude mice when given orally at 80 mg/kg/day for 10 days.
DescriptionOveractivity of epidermal growth factor receptor (EGFR) tyrosine kinase activity has been associated with a number of cancers. CL 387,785 is a potent, irreversible inhibitor of EGFR kinase activity (IC50 = 370 pM). It blocks EGF-stimulated autophosphorylation of receptors in cells (IC50 = 5 nM) and halts cell cycling in cells that overexpress EGFR or c-ErbB2 (IC50s = 31-125 nM). CL 387,785 profoundly blocks the growth of EGFR-overexpressing tumors in nude mice when given orally at 80 mg/kg/day for 10 days.
UsesCL-387785 (EKI-785) is an irreversible and selective EGFR inhibitor showing activity against mutations of the receptor. Potential therapeutic against various type of cancer, including lung cancer.
DefinitionChEBI: A member of the class of quinazolines that is 4,6-diaminoquinazoine in which the one of the hydrogens attached to the amino group at position 4 has been replaced by a m-bromophenyl group while one of the hydrogens attached to the amino group a position 6 has been replaced by a but-2-ynoyl group.
in vitrocl-387785 covalently bound to egfr. it also specifically inhibited kinase activity of the protein, blocked egf-stimulated autophosphorylation of the receptor in cells, inhibited cell proliferation primarily in a cytostatic manner in cell lines that overexpress egf-r or c-erbb-2 [1].
in vivothe effects of cl-387785 on tumor growth were assessed in human tumor xenografts implanted s.c. in the flanks of nude mice. cl-387785 inhibited the growth of tumors derived from a431 cells when the drug was administered i.p. or p.o.. inhibitory effects were observed within 7 days after the onset of therapy. no efficacy was observed with cl-387785 in tumors derived from cell lines that did not overexpress egf-r, including the human breast carcinoma mda-mb-435 [1].
IC 50370 pm
references[1] discafani cm, carroll ml, floyd mb jr, hollander ij, husain z, johnson bd, kitchen d, may mk, malo ms, minnick aa jr, nilakantan r, shen r, wang yf, wissner a, greenberger lm. irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by n-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (cl-387,785). biochem pharmacol. 1999 apr 15;57(8):917-25.
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- Preparation Products And Raw materials
Doxorubicin hydrochloride Canertinib Crenolanib AZD-1208 Ilomastat TYRPHOSTIN A25 L-4-THIAZOLYLALANINE 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide PF-04929113 IXABEPILONE Palbociclib Tariquidar Esomeprazole magnesium ZLN005 BLU 9931 1 NM-PP1 (-)-Blebbistatin Finasteride

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.